Management of Primary Dysmenorrhea
Start with NSAIDs at a loading dose (typically double the regular dose) at the onset of menstrual symptoms, followed by regular dosing until pain resolves; if NSAIDs fail after 3 menstrual cycles, add combined hormonal contraceptives. 1, 2
First-Line Treatment: NSAIDs
NSAIDs are the cornerstone of primary dysmenorrhea management because they directly target the pathophysiology—blocking prostaglandin synthesis that causes uterine hypercontractility and pain 2, 3.
Key implementation details:
- Begin NSAIDs at symptom onset or just before menstruation starts
- Use a loading dose (twice the standard dose) initially, then continue regular dosing 3
- Continue for 5-7 days or until symptoms resolve 4
- Common options include ibuprofen, naproxen, or mefenamic acid
Critical pitfall: Many patients take NSAIDs only after pain becomes severe. Emphasize starting at the first sign of symptoms or prophylactically for maximum efficacy.
Second-Line: Combined Hormonal Contraceptives
If NSAIDs fail after 3 menstrual cycles, add hormonal contraceptives rather than continuing ineffective NSAID monotherapy 3, 2. Combined hormonal contraceptives (CHCs) work by suppressing ovulation and reducing endometrial prostaglandin production.
Treatment algorithm:
- Trial CHCs for 3 cycles while continuing NSAIDs
- Can use extended or continuous regimens to reduce menstrual frequency
- If breakthrough bleeding occurs on extended regimens, consider a 3-4 day hormone-free interval (but not during first 21 days or more than once monthly) 4
When to Reassess for Secondary Causes
If symptoms persist after 6 months of combined NSAID and hormonal therapy, investigate for secondary dysmenorrhea, particularly endometriosis 3, 1. This is a critical decision point—persistent symptoms despite appropriate medical management warrant laparoscopy 3.
Red flags suggesting secondary dysmenorrhea requiring earlier investigation:
- Pain not responding to initial therapy
- Progressive worsening of symptoms
- Pain outside of menstruation
- Associated pelvic pathology on imaging
Adjunctive Therapies
Heat therapy provides meaningful benefit and can be used alongside pharmacologic treatment. Compared to NSAIDs, heat therapy achieves comparable pain relief (within 1.10 cm on a 10-cm VAS scale after 3 months) with significantly fewer adverse effects (RR 0.30) 5. This makes heat an excellent complementary option, particularly for patients with NSAID contraindications or intolerance.
Important Clinical Considerations
No pelvic examination is required to diagnose primary dysmenorrhea or initiate treatment 1, 6. This removes a significant barrier to care, especially in adolescents. Treatment should not be delayed pending definitive diagnosis.
Ultrasound is the preferred imaging modality if investigation is needed—transabdominal in non-sexually active patients, transvaginal in sexually active patients 6. However, imaging is not required before starting empiric therapy in patients with typical history.
The evidence strongly supports that primary dysmenorrhea is undertreated despite effective, low-cost therapies being widely available 1, 2. Persistent untreated menstrual pain may develop into chronic pain syndromes 1, making aggressive initial management critical for long-term outcomes.